tiprankstipranks
Trending News
More News >
Disc Medicine (IRON)
NASDAQ:IRON
US Market

Compare Disc Medicine (IRON) vs. Competitors

Compare
538 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Disc Medicine
$80.01
$3.10B
-14.93
46.14%
12 Buy
0 Hold
0 Sell
Strong Buy
Agios Pharma
$28.31
$1.67B
-4.07
-15.62%
6 Buy
3 Hold
0 Sell
Moderate Buy
Travere Therapeutics
$30.28
$2.69B
-27.92
43.51%
11 Buy
2 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$25.45
$3.23B
-71.79
82.70%
7 Buy
1 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$68.15
$2.89B
-31.88
25.70%
6 Buy
1 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$4.47
$2.39B
-2.47
-39.84%
2 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IRON
Disc Medicine
80.01
24.41
43.90%
AGIO
Agios Pharma
28.31
-6.23
-18.04%
TVTX
Travere Therapeutics
30.28
9.23
43.85%
ARQT
Arcutis Biotherapeutics
25.45
11.78
86.17%
TARS
Tarsus Pharmaceuticals
64.18
12.44
24.04%
RXRX
Recursion Pharmaceuticals
4.47
-3.22
-41.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts